Optimal Morphine Dosing Schedule for Neonatal Abstinence Syndrome

NCT04298853 · clinicaltrials.gov ↗

PHASE4

Phase

COMPLETED

Status

17

Enrollment

OTHER

Sponsor class

Conditions

Neonatal Abstinence Syndrome
Neonatal Opioid Withdrawal
Neonatal Opioid Withdrawal Syndrome

Interventions

DRUG: Morphine PRN
DRUG: Morphine scheduled

Sponsor

Indiana University